Occupe actuellement des postes chez Adaptimmune Therapeutics PLC and WAVE Life Sciences Ltd
Position | Company | Period |
---|---|---|
Chief Financial Officer | Adaptimmune Therapeutics PLC | 1 mars 2015 - |
Independent Director | WAVE Life Sciences Ltd | 1 février 2017 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
30 080
-40.1%
0,6720 244 USD |
30 080 -40.1% | 0,67 | 20 244 USD | |
2024-01-12 | 2024-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
17 257
-39.5%
0,8514 739 USD |
17 257 -39.5% | 0,85 | 14 739 USD | |
2024-01-12 | 2024-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
11 945
-39.4%
0,849 994 USD |
11 945 -39.4% | 0,84 | 9 994 USD | |
2023-09-01 | 2023-09-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 403
-41.1%
0,781 874 USD |
2 403 -41.1% | 0,78 | 1 874 USD | |
2023-06-27 | 2023-06-27 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 333
-39.9%
0,922 146 USD |
2 333 -39.9% | 0,92 | 2 146 USD | |
2023-01-17 | 2023-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
10 057
-43.0%
1,8618 686 USD |
10 057 -43.0% | 1,86 | 18 686 USD | |
2023-01-04 | 2023-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
5 073
-43.3%
1,698 594 USD |
5 073 -43.3% | 1,69 | 8 594 USD | |
2022-09-01 | 2022-09-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 536
-43.3%
1,974 993 USD |
2 536 -43.3% | 1,97 | 4 993 USD | |
2022-01-18 | 2022-01-18 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
11 096
-47.4%
3,1935 416 USD |
11 096 -47.4% | 3,19 | 35 416 USD | |
2022-01-13 | 2022-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
3 046
-47.6%
3,5410 795 USD |
3 046 -47.6% | 3,54 | 10 795 USD | |
2022-01-13 | 2022-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
14 362
-47.3%
3,5651 081 USD |
14 362 -47.3% | 3,56 | 51 081 USD | |
2022-01-05 | 2022-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
5 532
-47.3%
4,0622 483 USD |
5 532 -47.3% | 4,06 | 22 483 USD | |
2021-06-28 | 2021-06-28 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 794
-47.7%
4,3712 210 USD |
2 794 -47.7% | 4,37 | 12 210 USD | |
2021-01-19 | 2021-01-19 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
9 879
-42.2%
5,6756 009 USD |
9 879 -42.2% | 5,67 | 56 009 USD | |
2021-01-12 | 2021-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 707
-42.3%
6,1516 654 USD |
2 707 -42.3% | 6,15 | 16 654 USD | |
2021-01-05 | 2021-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
4 967
-42.4%
5,3326 464 USD |
4 967 -42.4% | 5,33 | 26 464 USD | |
2020-09-02 | 2020-09-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 776
-47.4%
8,5123 637 USD |
2 776 -47.4% | 8,51 | 23 637 USD | |
2020-08-04 | 2020-08-03 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 788
-47.6%
9,2525 789 USD |
2 788 -47.6% | 9,25 | 25 789 USD | |
2020-01-15 | 2020-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
3 236
-50.5%
5,1316 616 USD |
3 236 -50.5% | 5,13 | 16 616 USD | |
2020-01-07 | 2020-01-06 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
5 900
-50.4%
1,207 080 USD |
5 900 -50.4% | 1,20 | 7 080 USD | |
2019-01-16 | 2019-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
3 084
-48.2%
5,3716 559 USD |
3 084 -48.2% | 5,37 | 16 559 USD |